GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Net Income From Continuing Operations

Vilin Bio Med (NSE:VILINBIO) Net Income From Continuing Operations : ₹10.43 Mil (TTM As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Vilin Bio Med's net income from continuing operations for the six months ended in Sep. 2023 was ₹10.43 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2023 was ₹10.43 Mil.

Vilin Bio Med Net Income From Continuing Operations Historical Data

The historical data trend for Vilin Bio Med's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Net Income From Continuing Operations Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
Net Income From Continuing Operations
1.94 1.61 0.45

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
Net Income From Continuing Operations - - - 5.51 10.43

Vilin Bio Med Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹10.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:538965 BOM:542724 NSE:SAROJA BOM:511523 BOM:530665 BOM:532167 NSE:WALPAR BOM:524400 BOM:524752 BOM:523620 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Website
http://www.vilinbiomed.co.in
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines